Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]

Detalles Bibliográficos
Autores principales: Tan, Wenliang, Luo, Xuan, Li, Wenda, Zhong, Jinyi, Cao, Jun, Zhu, Sicong, Chen, Xianqing, Zhou, Rui, Shang, Changzhen, Chen, Yajin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127592/
https://www.ncbi.nlm.nih.gov/pubmed/35605430
http://dx.doi.org/10.1016/j.ebiom.2022.104074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127592/
https://www.ncbi.nlm.nih.gov/pubmed/35605430
http://dx.doi.org/10.1016/j.ebiom.2022.104074

Ejemplares similares